Erectile Dysfunction Completed Phase 1 Trials for Avanafil (DB06237)

Also known as: EDS / ED / Erectile difficulties / Erectile Dysfunction (ED) / Difficulty maintaining an erection / Decreased erections / Male Erectile Disorder / Male Erectile Dysfunction / Difficult erection / Inability to achieve or maintain erection / Erectile Dysfunctions / Male erectile dysfunction, unspecified / Erectile dysfunction (disorder) / Impotence / Erectile dysfunction NOS / Impotent / Erectile disturbance / Erection failure / Psychogenic impotence

IndicationStatusPhase
DBCOND0029956 (Erectile Dysfunction)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01616485Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and PlaceboTreatment
NCT01117038Drug Interaction Study of Avanafil and Enalapril or AmlodipineTreatment
NCT01100021Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and TamsulosinTreatment
NCT01095588Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male SubjectsTreatment
NCT01054430To Assess the Safety of Avanafil in Healthy and Hepatically Impaired Male Subjects.Treatment
NCT01054859A Phase I Crossover Study of the Hemodynamic Interactions of Avanafil & Alcohol in Healthy Male Subjects.Treatment
NCT00770042To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of AvanafilTreatment
NCT00769041A Thorough EKG Safety Study of TA-1790 (Avanafil)Treatment